Contract HHSO100201600015C
Takeda Vaccines Inc · Department Of Health And Human Services · September 22, 2021
Takeda Vaccines Inc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 22, 2021 for $100.44 million (current value) of work in in-vitro diagnostic substance manufacturing. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses cost-plus contract pricing. The most recent modification was on September 26, 2024. If all options are exercised, the contract could reach $335.33 million.
Contract details
- PIID
- HHSO100201600015C
- Award type
- Definitive Contract
- Pricing
- Cost Plus Fixed Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Health R&D Services; Health Care Services; Experimental Development
- First action
- September 22, 2021
- Latest action
- September 26, 2024
Description
TO DEOBLIGATE $7,416,267.20 IN UNUSED FUNDS
Modification timeline
-
September 26, 2024Mod P00018 · Funding Only Action$100.44M
-
September 22, 2021Mod P00011 · Other Administrative ActionTAKEDA ZIKA VIRUS$107.95M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Cepheid | Department Of Health And Human Services | July 2, 2026 | $756.3K |
| Remel Inc. | Department Of Health And Human Services | July 2, 2026 | $64.2K |
| Orasure Technologies Inc | Department Of Health And Human Services | July 1, 2026 | $1.05M |
| Biofire Defense Llc | Department Of Health And Human Services | July 1, 2026 | $222.2K |
| Becton, Dickinson And Company | Department Of Health And Human Services | July 1, 2026 | $21.4K |
| Mckesson Medical-Surgical Government Solutions Llc | Department Of Health And Human Services | June 30, 2026 | $160.0K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Biomerieux Inc | 182 | $25.50M |
| 2 | Cepheid | 114 | $20.70M |
| 3 | Roche Diagnostics Corporation | 125 | $13.00M |
| 4 | Quest Diagnostics Incorporated | 8 | $4.31M |
| 5 | Hologic Sales And Service, Llc | 39 | $3.88M |
| 6 | Beckman Coulter, Inc | 28 | $3.40M |
| 7 | Fisher Scientific Company L.L.C. | 52 | $3.04M |
| 8 | Werfen USA Llc | 91 | $2.75M |
| 9 | Diasorin Inc | 21 | $2.74M |
| 10 | Abbott Laboratories Inc. | 10 | $2.69M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSO100201600015C?
Contract HHSO100201600015C is a federal contract awarded to Takeda Vaccines Inc by Department Of Health And Human Services on September 22, 2021 for $100.44 million of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 1 time since the base award.
Who won contract HHSO100201600015C?
Takeda Vaccines Inc won contract HHSO100201600015C from Department Of Health And Human Services.
How much is contract HHSO100201600015C worth?
Contract HHSO100201600015C has obligated $0 to date but carries a potential ceiling of $335.33 million if fully funded and all options are exercised.